Forum Acquires Wisconsin Pharmacy Providing LTC-at-Home ServicesBy: Forum Extended Care Services, Inc CHICAGO - Nov. 14, 2022 - PRLog -- Forum Extended Care Services announces that the company has reached the final stages of integration with its acquisition of Willow Pharmacy, a Wisconsin-based pharmacy provider that serves individuals receiving long-term care (LTC) services at home. The move allows Forum to expand its reach further into Wisconsin and build on a proven and successful model for extending pharmacy services to the LTC-at-home population.
The acquisition creates a third pharmacy location for Illinois-headquartered Forum, allowing the company to strengthen its Midwest presence to more easily serve surrounding states, including Wisconsin, Missouri, Michigan, and Indiana. "Willow Pharmacy is a natural addition to Forum for many reasons, but most notably because we are blending two cultures and missions that are singularly focused on providing exceptional patient-centered services for seniors and disabled individuals," Forum and Willow utilize systems and processes to make medication management easy for caregivers, with a focus on reducing medication errors that are often a critical issue in the LTC population, ultimately improving health outcomes and quality of life. About Forum Extended Care Services For more than 50 years, Forum has delivered easy, accurate, and reliable pharmacy services to long-term and senior care. Accredited and open 24/7/365, Forum is a rock-solid partner, taking the drama out of pharmacy services so residents, facilities, and communities can thrive. Forum is proud to make meds easier for clients with two locations serving Illinois, Wisconsin, and Indiana. Forum was named as one of the 2022 Best Places to Work in Illinois by the statewide survey and awards program. For more information, visit www.forumpharmacy.com, call (800) 447-7108, or e-mail info@forumpharmacy.com. Media Contact Forum Extended Care Services, Inc. Pamela Kramer ***@forumpharmacy.com (847) 847-673-8727 x3302 End
Account Email Address Account Phone Number Disclaimer Report Abuse
|